US 10982212
Conserved HBV and HCV sequences useful for gene silencing
granted A61KA61K31/713A61P
Quick answer
US patent 10982212 (Conserved HBV and HCV sequences useful for gene silencing) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/713, A61P, A61P31/14, A61P31/20